Filing Details
- Accession Number:
- 0001415889-25-018438
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2025-06-27 19:35:22
- Reporting Period:
- 2025-06-26
- Filing Date:
- 2025-06-27
- Accepted Time:
- 2025-06-27 19:35:22
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1534133 | Calcimedica Inc. | CALC | Pharmaceutical Preparations (2834) | 452120079 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1576244 | W Eric Roberts | C/O Calcimedica, Inc. 505 Coast Blvd. S. #307 La Jolla CA 92037 | Chief Business Officer | No | No | No | No |
Transaction Summary
Purchased: | 4,500 shares | Avg. Price: $1.44 | Total Value: $6,482.70 |
Number of Shares After Transactions: | 32,823 shares |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2025-06-26 | 4,500 | $1.44 | 32,823 | No | 4 | P | Indirect | By FMTC Custodian - Roth IRA FBO Eric W. Roberts |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | P | Indirect | By FMTC Custodian - Roth IRA FBO Eric W. Roberts |
Reported Non-Derivative Holdings
Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
---|---|---|---|
Common Stock | 164,706 | Direct | |
Common Stock | 49,894 | Indirect | By Oppenheimer & Co Inc. Custodian FBO Eric W Roberts Roth IRA |
Common Stock | 10,661 | Indirect | By IRA Financial Trust Company CFBO Eric W. Roberts |
Common Stock | 356,989 | Indirect | By Valence Investments SPV IV, LLC |
Common Stock | 66,228 | Indirect | By Valence Investments SPV V, LLC |
Common Stock | 316,109 | Indirect | By Valence Investments SPV VI, LLC |
Footnotes
- The weighted average purchase price for the transaction reported was $1.4406, and the range of prices were between $1.43 and $1.4499. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares purchased at each separate price will be provided.